About Biodesix (BDSX)
Biodesix, Inc. operates as a biotechnology company. The Company offers non-small cell lung cancer pretreatment serum tests and laboratory testing. Biodesix provides diagnostic tools and equipment for blood and tissue analysis in the United States.
- USD0.54
- USD0.58
- USD0.51
- USD2.04
- -17.50%
- 71M
- 244.03k
- 374.51k
- 79M
- 0.45
- -60.50%
Stock News
2 hours ago
Warren Buffett to step down as Berkshire CEO at year-end
MarketWatch
5 hours ago
How Capital One can get an even bigger payoff from its Discover purchase
CNBC
7 hours ago
Bank of the James Financial Group First Quarter 2025 Earnings: EPS: US$0.18 (vs US$0.48 in 1Q 2024)
Yahoo
7 hours ago
Brain health experts' top 3 tips for lowering your risk of dementia, stroke and depression—all at the same time
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
